Influence of alternative mammographic screening scenarios on breast cancer incidence predictions (Finland)

Cancer Causes and Control

Volumn 17, Issue 9, 2006, Pages 1135-1144

  Seppänen, Johanna ^a   Heinävaara, Sirpa ^a,b,c   Hakulinen, Timo ^a  

^a FINNISH CANCER REGISTRY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

Author keywords

Breast cancer; Incidence; Mass screening; Prediction

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SCREENING; FEMALE; FINLAND; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL PRACTICE; POISSON DISTRIBUTION; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; FEMALE; FINLAND; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS;

EID: 33749151894     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-006-0055-1     Document Type: Article

References (17)

1. Møller B, Weedon-Fekjær H, Hakulinen T, et al (2005) The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev 14:117-128
2. Møller B, Fekjær H, Hakulinen T, et al (2002) Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 11:Suppl 1
3. Sarkeala T, Anttila A, Forsman H, Luostarinen T, Saarenmaa I, Hakama M (2004) Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer 40:2116-2125
4. Seppänen J, Heinävaara S, Anttila A, Sarkeala T, Virkkunen H, Hakulinen T (2006) Effects of different phases of an invitational screening program on breast cancer incidence. Int J Cancer 119:920-924
5. Teppo L, Pukkala E, Lehtonen M (1994) Data quality and quality control of a population-based cancer registry: Experience in Finland. Acta Oncol 33:365-369
6. IARC Working Group on the Evaluation of Cancer-Preventive Strategies (2002) Breast cancer screening. IARC Handbooks of Cancer Prevention, vol. 7 Lyon: IARC, pp.17-21
7. Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 6:449-467
8. Finnish Cancer Registry (2003) Cancer Incidence in Finland 2000 and 2001. Helsinki: Cancer Society of Finland Publication No. 65
9. Møller B, Fekjær H, Hakulinen T, et al (2003) Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med 22:2751-2766
10. Hakulinen T, Dyba T (1994) Precision of incidence predictions based on Poisson distributed observations. Stat Med 13:1513-1523
11. Møller B, Weedon-Fekjær H, Haldorsen T (2005) Empirical evaluation of prediction intervals for cancer incidence. BMC Medical Research Methodology 5:21
12. Clements M, Armstrong BK, Moolgavkar SH (2005) Lung cancer rate predictions using generalized additive models. Biostatistics 1:1-25
13. Boer R, Warmerdam P, de Koning H, van Oortmarssen G (1994) Extra incidence caused by mammographic screening. Lancet 343:979
14. Gao YT, Shu XO, Dai Q, et al (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai breast cancer study. Int J Cancer 87:295-300
15. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288:321-333
16. Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Official J Eur Union. Brussels
17. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H (1993) Trends in cancer incidence and mortality. IARC Scientific Publications No 121. Lyon: IARC